CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Phase I/IIa trial in combination with MabThera (rituximab) in patients with relapsed/refractory NHL; and CB-5339, which is in Phase I clinical trial for acute myeloid leukemia and myelodysplastic syndrome. Its product pipeline also comprises CID-103 for the treatment of patients with multiple myeloma; Thiotepa, which has multiple indications including use as a conditioning treatment for various allogeneic haemopoietic stem cell transplants; and Octreotide long acting injectable formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumors. The company has licensing agreements with Juventas Cell Therapy Ltd; BioInvent International AB; Black Belt Therapeutics Limited; and Cleave Therapeutics, Inc. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Rockville, Maryland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of CASI Pharmaceuticals Inc..
CASI Pharmaceuticals Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of CASI Pharmaceuticals Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of CASI Pharmaceuticals Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of CASI Pharmaceuticals Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of CASI Pharmaceuticals Inc. and all latest updates of the company are provided.
The 2025 version of CASI Pharmaceuticals Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 CASI Pharmaceuticals Inc.- Key Facts
2.2 CASI Pharmaceuticals Inc.- Geographic Locations
2.3 CASI Pharmaceuticals Inc.- Subsidiaries and Affiliates
2.4 CASI Pharmaceuticals Inc.- Business Divisions
2.5 CASI Pharmaceuticals Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. CASI Pharmaceuticals Inc. Strategic Analysis Review
3.1 CASI Pharmaceuticals Inc.- Key Strategies
3.2 CASI Pharmaceuticals Inc.- Company Outlook Statement
3.3 CASI Pharmaceuticals Inc.- SWOT Analysis
3.3.1 CASI Pharmaceuticals Inc.- Key Strengths
3.3.2 CASI Pharmaceuticals Inc.- Key Weaknesses
3.3.3 CASI Pharmaceuticals Inc.- Potential Opportunities
3.3.4 CASI Pharmaceuticals Inc.- Potential Threats
3.4 CASI Pharmaceuticals Inc.- Key Competitors
4. Business Description of the Company
4.1 CASI Pharmaceuticals Inc.- Business Overview
4.2 CASI Pharmaceuticals Inc.- Operations by Segment
5 Products and Services Details
5.1 CASI Pharmaceuticals Inc.- Key Products
5.2 CASI Pharmaceuticals Inc.- Key Service Areas
5.3 CASI Pharmaceuticals Inc.- Key Brands
6 Company Developments
6.1 CASI Pharmaceuticals Inc.- Company History
6.2 CASI Pharmaceuticals Inc.- Latest Developments
7 Financial Analysis
7.1 CASI Pharmaceuticals Inc.- Income Statements
7.2 CASI Pharmaceuticals Inc.- Balance Sheet
7.3 CASI Pharmaceuticals Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 CASI Pharmaceuticals Inc.- Direct Competitors
8.2 CASI Pharmaceuticals Inc.- Competitor Financial Ratios comparison
8.3 CASI Pharmaceuticals Inc.- Competitor Stock Charts Comparison
8.4 CASI Pharmaceuticals Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
